Technology
Health
Biotechnology

Xenon Pharmaceuticals

$10.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.02 (0.20%) As of 3:19 PM EDT today
+$0.02 (0.20%) Today

Why Robinhood?

You can buy or sell XENE and other stocks, options, ETFs, and crypto commission-free!

About XENE

Xenon Pharmaceuticals, Inc. engages in discovering and developing therapeutics to improve the lives of patients with neurological disorders. It focuses on the treatment of epilepsy. Read More Its products include XEN496, XEN1101, XEN901, and XEN007. The company was founded by Simon Neil Pimstone, Johannes J. P. Kastelein, and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Employees
92
Headquarters
Burnaby, British Columbia
Founded
1996
Market Cap
261.07M
Price-Earnings Ratio
Dividend Yield
Average Volume
44.79K
High Today
$10.16
Low Today
$9.80
Open Price
$10.00
Volume
26.44K
52 Week High
$15.92
52 Week Low
$5.41

Collections

Technology
Health
Biotechnology
Therapy
2014 IPO
Canada
North America

XENE Earnings

-$0.63
-$0.46
-$0.28
-$0.11
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.